{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T23:56:14Z","timestamp":1733874974873,"version":"3.30.1"},"reference-count":14,"publisher":"CAIRN","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,22]]},"abstract":"<jats:p>Introduction\u00a0: Le syndrome de rub\u00e9ole cong\u00e9nitale est une pathologie cons\u00e9cutive \u00e0 une infection maternelle puis f\u0153tale par le virus de la rub\u00e9ole pouvant induire de lourdes s\u00e9quelles chez l\u2019enfant. L\u2019incidence de ce syndrome a conduit un grand nombre de pays \u00e0 introduire des vaccins \u00e0 valence rub\u00e9ole dans leur programme de vaccination. Objectif\u00a0: Afin d\u2019estimer la s\u00e9ropr\u00e9valence de cette maladie et \u00e9valuer l\u2019oppotunit\u00e9 d\u2019introduire le vaccin antirub\u00e9oleux, une \u00e9tude transversale descriptive a \u00e9t\u00e9 men\u00e9e au Niger de 2005 \u00e0 2019. Toutes les r\u00e9gions du Niger \u00e9taient concern\u00e9es par l\u2019\u00e9tude. M\u00e9thode\u00a0: Il s\u2019agissait d\u2019une revue documentaire r\u00e9alis\u00e9e \u00e0 partir de la base de donn\u00e9es de la surveillance \u00e9pid\u00e9miologique de la rougeole (2005-2019). Dans ce cadre, nous avons \u00e9tudi\u00e9 5\u00a0170\u00a0\u00e9chantillons s\u00e9rologiquement n\u00e9gatifs des cas suspects de rougeole en r\u00e9alisant un test \u00c9lisa \u00e0 la recherche des IgM antirub\u00e9oleuses. R\u00e9sultats\u00a0: Sur cette base des donn\u00e9es, 7\u202f% (366\/5170) des cas suspects de rougeole \u00e9taient des cas de rub\u00e9ole. L\u2019\u00e2ge m\u00e9dian \u00e9tait de 6\u00a0ans avec un intervalle interquartile de 0 \u00e0 69\u00a0ans. La rub\u00e9ole \u00e9tait fr\u00e9quente dans toutes les tranches d\u2019\u00e2ge, avec une pr\u00e9dominance parmi les tranches d\u2019\u00e2ge 24-59\u00a0mois (36,1\u202f%) et 5-9\u00a0ans (33,6\u202f%). Parmi ces cas, 52,8\u202f% \u00e9taient des hommes, 47, 2\u202f% des femmes avec un sexe-ratio de 1,1. La rub\u00e9ole a \u00e9t\u00e9 retrouv\u00e9e dans toutes les r\u00e9gions du Niger, avec une pr\u00e9dominance dans les r\u00e9gions de Maradi (28,8\u202f%), de Tahoua (17\u202f%), et de Zinder (15,5\u202f%). La moiti\u00e9 (53\u202f%) des personnes atteintes par la rub\u00e9ole provenaient des zones rurales, 47\u202f% des zones urbaines. Au cours de cette \u00e9tude, la majorit\u00e9 des cas \u00e9taient notifi\u00e9s de janvier \u00e0 avril, avec un pic en avril.<\/jats:p>","DOI":"10.3917\/spub.214.0591","type":"journal-article","created":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T09:51:40Z","timestamp":1645177900000},"page":"591-596","source":"Crossref","is-referenced-by-count":1,"title":["S\u00e9ropr\u00e9valence de la rub\u00e9ole au Niger de 2005 \u00e0 2019\u2008: estimations issues du syst\u00e8me de surveillance \u00e9pid\u00e9miologique de la rougeole"],"prefix":"10.3917","volume":"Vol. 33","author":[{"given":"Amadou","family":"Moumouni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Doingal\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douthi","family":"Mahamadou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tour\u00e9","family":"Attoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issiaka","family":"Tiembr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2273","reference":[{"key":"rb1","isbn-type":"print","doi-asserted-by":"publisher","first-page":"735-771","DOI":"10.1016\/B978-1-4160-3611-1.50033-7","volume-title":"Rubella vaccine","author":"Plotkin Stanley A.","year":"2008","ISBN":"https:\/\/id.crossref.org\/isbn\/9781416036111","journal-title":"Vaccines"},{"unstructured":"2 http:\/\/www.who.int\/wer World Health Organization (WHO). Weekly epidemiological record (WER). WHO. 2010;85(42):413-24. .","key":"rb2"},{"unstructured":"3 https:\/\/www.who.int\/publications\/i\/item\/global-vaccine-action-plan-2011-2020 WHO. Global vaccine action plan\u00a02011-2020. Geneva: WHO; 2013 [Visit\u00e9 le 05\/11\/2021]. En ligne\u00a0: .","key":"rb3"},{"key":"rb4","doi-asserted-by":"publisher","first-page":"S239-S242","DOI":"10.1093\/infdis\/jir120","article-title":"The Epidemiology of Rubella Disease in Ethiopia: Data From the Measles Case-Based Surveillance System","volume":"204","author":"Mitiku Kassahun","year":"2011","journal-title":"The Journal of Infectious Diseases","ISSN":"https:\/\/id.crossref.org\/issn\/0022-1899","issn-type":"print"},{"key":"rb5","doi-asserted-by":"publisher","first-page":"null","DOI":"10.1186\/s12889-016-3841-z","article-title":"Epidemiology of rubella virus cases in the pre-vaccination era of Ethiopia, 2009\u20132015","volume":"16","author":"Getahun Mekonen","year":"2016","journal-title":"BMC Public Health","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2458","issn-type":"print"},{"key":"rb6","doi-asserted-by":"publisher","first-page":"null","DOI":"10.1186\/s13052-017-0379-3","article-title":"Rubella sero-prevalence among children in Kilimanjaro region: a community based study prior to the introduction of rubella vaccine in Tanzania","volume":"43","author":"Chotta Nikolas A. S.","year":"2017","journal-title":"Italian Journal of Pediatrics","ISSN":"https:\/\/id.crossref.org\/issn\/1824-7288","issn-type":"print"},{"doi-asserted-by":"crossref","unstructured":"7 https:\/\/doi.org\/10.7717\/peerj.580 Umeh CA, Onyi SC. Case-based rubella surveillance in Abia State, South East Nigeria, 2007-2011. PeerJ; 2014;2:e580. .","key":"rb7","DOI":"10.7717\/peerj.580"},{"key":"rb8","doi-asserted-by":"publisher","first-page":"null","DOI":"10.1186\/s13052-016-0264-5","article-title":"Serological evidence of acute rubella infection among under-fives in Mwanza: a threat to increasing rates of congenital rubella syndrome in Tanzania","volume":"42","author":"Mirambo Mariam M.","year":"2016","journal-title":"Italian Journal of Pediatrics","ISSN":"https:\/\/id.crossref.org\/issn\/1824-7288","issn-type":"print"},{"key":"rb9","doi-asserted-by":"publisher","first-page":"11-15","DOI":"10.1016\/j.patbio.2003.05.001","article-title":"\u00c9tude de l\u2019infection par le virus de la rub\u00e9ole chez l\u2019enfant et l\u2019adolescent en Tunisie","volume":"52","author":"Boubaker S.Haddad","year":"2004","journal-title":"Pathologie Biologie","ISSN":"https:\/\/id.crossref.org\/issn\/0369-8114","issn-type":"print"},{"doi-asserted-by":"crossref","unstructured":"10 Omoleke\u00a0SA, Udenenwu\u00a0HC. Incidence of rubella in a state in North-western Nigeria: a call for action. Pan Afr Med J. 2016;25:49.","key":"rb10","DOI":"10.11604\/pamj.2016.25.49.10003"},{"key":"rb11","doi-asserted-by":"publisher","first-page":"1256-1260","DOI":"10.15585\/mmwr.mm6645a4","article-title":"Progress in Rubella and Congenital Rubella Syndrome Control and Elimination \u2014 Worldwide, 2000\u20132016","volume":"66","author":"Grant Gavin B.","year":"2017","journal-title":"MMWR. Morbidity and Mortality Weekly Report","ISSN":"https:\/\/id.crossref.org\/issn\/0149-2195","issn-type":"print"},{"key":"rb12","doi-asserted-by":"publisher","first-page":"60-64","DOI":"10.1080\/23120053.2014.11441571","article-title":"Epidemiology of rubella disease in south-west nigeria: trends and projection from measles case-based surveillance data","volume":"29","author":"Fatiregun A A","year":"2014","journal-title":"Southern African Journal of Infectious Diseases","ISSN":"https:\/\/id.crossref.org\/issn\/2312-0053","issn-type":"print"},{"doi-asserted-by":"crossref","unstructured":"13 https:\/\/doi.org\/10.1136\/bmjopen-2016-012959 Nimpa\u00a0Mengouo\u00a0M, Ndze\u00a0VN, Baonga\u00a0F, Kobela\u00a0M, Wiysonge\u00a0CS. Epidemiology of rubella infection in Cameroon: a 7-year experience of measles and rubella case-based surveillance, 2008-2014. BMJ Open. 2017;7(4):e012959. .","key":"rb13","DOI":"10.1136\/bmjopen-2016-012959"},{"key":"rb14","doi-asserted-by":"publisher","first-page":"248-254","DOI":"10.1016\/j.jcv.2014.07.003","article-title":"Clinical epidemiological and molecular aspects of rubella outbreak with high number of neurological cases, Tunisia 2011\u20132012","volume":"61","author":"Messedi Emna","year":"2014","journal-title":"Journal of Clinical Virology","ISSN":"https:\/\/id.crossref.org\/issn\/1386-6532","issn-type":"print"}],"container-title":["Sant\u00e9 Publique"],"original-title":[],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T01:48:53Z","timestamp":1697161733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cairn.info\/revue-sante-publique-2021-4-page-591.htm?ref=doi"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[2021,11,22]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,11,22]]}},"URL":"https:\/\/doi.org\/10.3917\/spub.214.0591","relation":{},"ISSN":["0995-3914"],"issn-type":[{"type":"print","value":"0995-3914"}],"subject":[],"published":{"date-parts":[[2021,11,22]]}}}